echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Blood System > PNAS: Scientists have designed new drug compounds to curb malaria

    PNAS: Scientists have designed new drug compounds to curb malaria

    • Last Update: 2021-05-21
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Malaria remains a major global health threat.


    Malaria remains a major global health threat.


    The pathogen of malaria is a single-celled parasite that invades and replicates in red blood cells.


    If the parasite can be effectively trapped in the cell by blocking the parasite's exit pathway, it may be possible to prevent the spread of the disease during its course and stop the destructive cycle of its invasion of cells.


    Recently , in a study published in PNAS , scientists have developed a set of compounds that can directly inhibit the activity of SUB1 to prevent parasites from erupting from red blood cells and from proliferating.


    d org/10.


    d org/10.


    The compound works by blocking an enzyme called SUB1, which is essential for the outbreak of malaria from red blood cells.


    Develop rationally designed peptide PfSUB1 inhibitors.


    Develop rationally designed peptide PfSUB1 inhibitors.


    Peptide boric acid PfSUB1 inhibitor prevents the escape of Plasmodium falciparum

     

    Importantly, the compound can also pass through the membranes of red blood cells and the intracellular compartments where the parasites are located.


    Importantly, the compound can also pass through the membranes of red blood cells and the intracellular compartments where the parasites are located.


    The schematic diagram shows that the inhibitor of SUB1 needs to pass through at least two to four layers of membrane to enter and inactivate the parasite in the red blood cell.


    The schematic diagram shows that the inhibitor of SUB1 needs to pass through at least two to four layers of membrane to enter and inactivate the parasite in the red blood cell.


    The team is continuing to optimize the compound to make it smaller and more effective.


    Chrislaine Withers-Martinez, author and researcher at the Malaria Biochemistry Laboratory, said: “Many existing antimalarials are plant-derived.


    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.